Systemic sclerosis and occupational risk factors: Role of solvents and cleaning products

Journal of Rheumatology

Volumn 31, Issue 12, 2004, Pages 2395-2401

  Maître, Anne ^a   Hours, Martine ^b   Bonneterre, Vincent ^a   Arnaud, Joëlle ^a   Arslan, Marie Tülin ^b   Carpentier, Patrick ^c   Bergeret, Alain ^b   De Gaudemaris, Régis ^a,d  

^a Lab Physiologie et Pharmacologie   (France)

^b UNIVERSITÉ LYON 1   (France)

^c GRENOBLE UNIVERSITY HOSPITAL   (France)

^d UNIV GRENOBLE ALPES   (France)

Author keywords

Cleaning products; Occupational exposure; Scleroderma; Solvents; Systemic sclerosis

Indexed keywords

ADHESIVE AGENT; SOLVENT;

ADULT; ARTICLE; CLEANING; CONSTRUCTION WORK; CONTROLLED STUDY; EDUCATION; FEMALE; FRANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; OCCUPATIONAL SAFETY; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS; WORKPLACE;

ADULT; AGE DISTRIBUTION; CONFIDENCE INTERVALS; FEMALE; FOLLOW-UP STUDIES; FRANCE; HOUSEHOLD PRODUCTS; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; ODDS RATIO; RISK ASSESSMENT; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SOLVENTS;

EID: 10044253335     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Silman AJ, Newman J. Epidemiology of systemic sclerosis. Curr Opin Rheumatol 1996;8:585-9.
2. Mayes MD. Epidemiology of systemic sclerosis and related diseases. Curr Opin Rheumatol 1997;9:557-61.
3. Medsger TA, Masi AT. The epidemiology of systemic sclerosis (scleroderma) among male U.S. veterans. J Chronic Dis 1978;31:73-85.
4. Michel CJ, McKenna CH, Elveback LR, Kaslow RA, Kurland LT. Epidemiology of systemic lupus erythematosus and other connective tissue diseases in Rochester, Minnesota, 1950 through 1979. Mayo Clin Proc 1985;60:105-13.
5. Maricq HR, Weinrich MC, Kel JE, et al. Prevalence of scleroderma spectrum disorders in the general population of South Carolina. Arthritis Rheum 1989;32:998-1006.
6. Geirsson AJ, Steinsson K, Guthmundsson S, Sigurthsson V. Systemic sclerosis in Iceland. A nationwide epidemiological study. Ann Rheum Dis 1994;53:502-5.
7. INRS. Tableau no. 25. In: Maladies professionelles. Paris: INRS; 2000;328.
8. Bovenzi M, Barbone F, Betta A, Tommasini M, Versini W. Scleroderma and occupational exposure. Scand J Work Environ Health 1995;21:289-92.
9. Diot E, Lesire V, Guilmot JL, et al. Systemic sclerosis and occupational risk factors: a case control study. Occup Environ Med 2002;59:545-9.
10. Goldman JA. Connective tissue disease in people exposed to organic chemical solvents. J Clin Rheumatol 1996;2:185-90.
11. Schaeverbeke T, Halle O, Moride Y, et al. Systemic sclerosis and prolonged exposure to toxins [abstract]. Arthritis Rheum 1995;38 Suppl 9:S332.
12. Laing T, Gillespie B, Burns C, et al. Risk factors for scleroderma among Michigan women [abstract]. Arthritis Rheum 1995;38 Suppl 9:S341.
13. Freni-Titulaer LWJ, Kelley DB, Grow AG, McKinley TW, Arnatt FC, Hochberg MC. Connective tissue disease in Southeastern Georgia: a case-control study of etiologic factors. Am J Epidemiol 1989;130:404-9.
14. Cooper C, Dennison E. Do silicone breast implants cause connective tissue disease. BMJ 1998;316:403-4.
15. Burns CJ, Laing TJ, Gillespie BW, et al. The epidemiology of scleroderma among women: assessment of risk from exposure to silicone and silica. J Rheumatol 1996;23:1904-11.
16. Carpentier P, Feuillade ML, Santacreu M, Arnaud J, Imbert BAF. Variations géographiques de la prévalence et de l'incidence de la sclérodermie systémique. Rev Med Interne 1999;20:560.
17. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
18. Maricq HR, Weinrich MC. Diagnosis of Raynaud's phenomenon assisted by color charts. J Rheumatol 1988;15:454-9.
19. Bureau International du Travail. Classification internationale type des professions. Geneve: Organisation Internationale du Travail; 1991.
20. Siemiatycki J, Fritschi L, Nadon LMG. Reliability of an expert rating procedure for retrospective assessment of occupational exposures in community-based case-control studies. Am J Ind Med 1997;3:280-6.
21. Lundberg I, Alfredsson L, Plato N, Sverdrup B, Klareskog L, Kleinau S. Occupation, occupational exposure to chemicals and rheumatological disease, a register based cohort study. Scand J Rheumatol 1994;23:305-10.
22. Hours M, Dananche B, Fevotte J, et al. Bladder cancer and occupational exposures. Scand J Work Environ Health 1994;20:322-30.
23. Lazareth L. Sclérodermie systemique et connectivites. In: Vayssairat M, Carpentier P. Microcirculation clinique. Paris: Masson; 1996:228.
24. Silman AJ, Jones S. What is the contribution of occupational environmental factors to the occurrence of scleroderma in men? Ann Rheum Dis 1992;51:1322-4.
25. Englert HS, Davis K, O'Connor H, Chambers P, Brooks P. Male systemic sclerosis and occupational silica exposure: a population-based study. Aust NZJ Med 2000;30:215-30.
26. Bovenzi M, Barbone F, Pisa FE, et al. A case-control study of occupational exposures and systemic sclerosis. Int Arch Occup Environ Health 2004;77:10-6.
27. Lambert M, Hatron PY, Hachulla E, Devulder B. Hypothenar hammer syndrome followed by systemic sclerosis. J Rheumatol 2000;27:2516-7.
28. Noel B. Occupational factors in systemic sclerosis [letter]. J Rheumatol 2001;28:2139-40.
29. Nieten PJ, Sutherland SE, Silver RM, et al. Is occupational organic solvent exposure a risk factor for scleroderma? Arthritis Rheum 1998;41:1111-8.
30. Aryal BJ, Khuder SA, Schaub EA. Meta-analysis of systemic sclerosis and exposure to solvents. Am J Ind Med 2001;40:271-4.